Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.84 USD | +0.73% | +13.91% | +55.51% |
May. 07 | Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday | MT |
May. 07 | Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating | MT |
Financials (USD)
Sales 2024 * | 1.22B | Sales 2025 * | 1.52B | Capitalization | 2.97B |
---|---|---|---|---|---|
Net income 2024 * | 39M | Net income 2025 * | 67M | EV / Sales 2024 * | 2.26 x |
Net cash position 2024 * | 217M | Net cash position 2025 * | 418M | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
85.2
x | P/E ratio 2025 * |
47.4
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.23% |
Latest transcript on Hims & Hers Health, Inc.
1 day | +0.73% | ||
1 week | +13.91% | ||
Current month | +10.45% | ||
1 month | +4.69% | ||
3 months | +37.71% | ||
6 months | +79.51% | ||
Current year | +55.51% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 38 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 83 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 234 M€ | +7.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 13.84 | +0.73% | 5,397,204 |
24-05-14 | 13.74 | +6.59% | 8,719,079 |
24-05-13 | 12.89 | +4.88% | 7,092,419 |
24-05-10 | 12.29 | -4.88% | 7,000,486 |
24-05-09 | 12.92 | +6.34% | 10,467,561 |
Delayed Quote Nyse, May 15, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.51% | 2.97B | |
-40.56% | 2.17B | |
+115.18% | 703M | |
+13.39% | 489M | |
-67.87% | 142M |
- Stock Market
- Equities
- HIMS Stock